Second, because multiple COVID-19–induced cytokines redundantly activate the JAK/STAT pathway to induce APOL1 expression, a therapeutic strategy based on selective removal or inhibition of any 1 cytokine is unlikely to be effective in preventing or treating COVAN. Here, APOL1 is linked to COVID-19.